NCT06152289 Development of New Diagnostic Tools in Capsule Endoscopy
| NCT ID | NCT06152289 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Condition | Bowel Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2023-02-10 |
| Primary Completion | 2028-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2023-02-10 with a primary completion date of 2028-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Patients participating to this study will provide images and videos of capsule endoscopy to train, tune and evaluate technological bricks of artificial intelligence solutions, in order to improve diagnostic performances of the procedure, while reducing reading time by physicians.
Eligibility Criteria
Inclusion Criteria: \- Any patient in whom a capsule endoscopy examination is performed as part of routine care. Exclusion Criteria: \- Opposition to the use of images and videos from daily, routine care for research purposes.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06152289 clinical trial?
This trial is open to participants of all sexes, studying Bowel Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06152289 currently recruiting?
Yes, NCT06152289 is actively recruiting participants. Contact the research team at Xavier.dray@aphp.fr for enrollment information.
Where is the NCT06152289 trial being conducted?
This trial is being conducted at Paris, France.
Who is sponsoring the NCT06152289 clinical trial?
NCT06152289 is sponsored by Assistance Publique - Hôpitaux de Paris. The trial plans to enroll 10,000 participants.